Aralez Acquires U.S. Rights to AstraZeneca Beta-Blocker Toprol-XL and it’s authorized generic version
Aralez Pharmaceuticals completed its acquisition of U.S. rights from AstraZeneca to the branded and authorized generic versions of the beta-blocker Toprol-XL® (metoprolol... Read More